Larry Kociolek to Treatment Outcome
This is a "connection" page, showing publications Larry Kociolek has written about Treatment Outcome.
Connection Strength
0.216
-
Fidaxomicin for the treatment of Clostridioides difficile in children. Future Microbiol. 2020 07; 15:967-979.
Score: 0.064
-
An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children. J Pediatric Infect Dis Soc. 2019 Dec 27; 8(6):580-584.
Score: 0.062
-
Efficacy of atropine as a chronotropic agent in heart transplant patients undergoing dobutamine stress echocardiography. Echocardiography. 2006 May; 23(5):383-7.
Score: 0.024
-
Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Pediatric Patients. J Pediatr Gastroenterol Nutr. 2023 04 01; 76(4):440-446.
Score: 0.019
-
Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021. MMWR Morb Mortal Wkly Rep. 2021 12 31; 70(5152):1766-1772.
Score: 0.018
-
Ideal and Actual Impact of Rapid Diagnostic Testing and Antibiotic Stewardship on Antibiotic Prescribing and Clinical Outcomes in Children With Positive Blood Cultures. Pediatr Infect Dis J. 2019 02; 38(2):131-137.
Score: 0.015
-
Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):210-218.
Score: 0.014